IP Library Granted Patent US 8,146,587
Granted Patent B2
US 8,146,587 · App. 12/787,576 · Granted Apr 3, 2012

Method for nasal irrigation and drug delivery

Assignee: MedInvent, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,146,587
App. No.
12/787,576
Granted
Apr 3, 2012
Kind
B2
Abstract

A method of treating neoplasms of the nasal cavity. Fluid containing corticosteroids held in a canister is atomized via a compressed air supply to create particles sized for penetration and retention in the nasal cavity under pressure that is able to stent open the soft tissues of the nose to deliver the resultant mist into the whole of the nasal passages without the need for the patient to create an airstream through inhalation. The device consists of a main canister with a reservoir to hold the fluid, two air outlets and an insert that is placed over the air outlets, the insert having at least one outlet that is larger than the holes in the air outlet and allows the fluid to be atomized and injected directly into the nasal cavity.

Claims (11)

1. A method of treating neoplasms of the nasal cavity, comprising:

(a) providing fluid in a canister, wherein the canister includes a reservoir and at least two air exit ports and an insert, said insert comprising a base that fits within the canister; and wherein said fluid contains corticosteroids;

(b) mating said air exit ports to corresponding fluid channels, wherein the fluid channels comprise two tubes ending in a common bell housing above the base of the insert and wherein the fluid channels are larger in diameter than the air exit ports, thereby providing a space between the outer surface of the air exit ports and the inner surface of the fluid channels that allows fluid from said reservoir to be drawn upward between the air exit ports and fluid channels; and

(c) pumping pressurized air through said air exit ports, thereby creating a venturi effect that draws fluid from said reservoir upward between the air exit ports and fluid channels and expels the fluid as a mist in an aerosol plume through exit holes in the fluid channels and into a user's nasal cavity above the inferior nasal turbinate independent of the user's breathing, said mist comprising a particle size of up to 100 microns and covering the whole nasal cavity within one minute;

wherein said pressurized air has a pressure of 0.069-1.035 bar and an airflow rate of 1-12 liters per minute, producing a fluid delivery rate of 10-20 ml per minute.

2. The method according to claim 1 , wherein said fluid contains antibiotics.

3. The method according to claim 1 , wherein the mist delivers up to 60 mg of corticosteroids to the nasal cavity within one minute.

4. The method according to claim 1 , wherein said pressurized air has a pressure of 0.276-0.552 bar.

5. The method according to claim 1 , wherein said pressurized air has an airflow rate of 6-8 liters per minute.

6. The method according to claim 1 , wherein the fluid delivery rate is 15 ml per minute.

7. The method according to claim 1 , wherein the particle size is at least 10 microns.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded May 19, 2022
From: NASONEB, INC.; MONAGHAN MEDICAL CORPORATION
To: MONAGHAN MEDICAL CORPORATION
Reel/Frame 059962/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2018
From: MEDINVENT, LLC
To: NASONEB, INC.
Reel/Frame 045480/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2011
From: FLICKINGER, WILLIAM J.; QUACKENBUSH, JOHN
To: MEDINVENT, LLC
Reel/Frame 026168/0531 →
Continuity (2)
Continuation In Part 12633269 · Dec 8, 2009
Related Publication 20110132354A1 · Jun 9, 2011